Dawei Chen

9.2k total citations
230 papers, 7.6k citations indexed

About

Dawei Chen is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Dawei Chen has authored 230 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Molecular Biology, 87 papers in Biomaterials and 65 papers in Biomedical Engineering. Recurrent topics in Dawei Chen's work include Nanoparticle-Based Drug Delivery (80 papers), RNA Interference and Gene Delivery (76 papers) and Nanoplatforms for cancer theranostics (56 papers). Dawei Chen is often cited by papers focused on Nanoparticle-Based Drug Delivery (80 papers), RNA Interference and Gene Delivery (76 papers) and Nanoplatforms for cancer theranostics (56 papers). Dawei Chen collaborates with scholars based in China, United States and Hong Kong. Dawei Chen's co-authors include Haiyang Hu, Mingxi Qiao, Xiuli Zhao, Jiulong Zhang, Jing Qin, Lifang Cheng, Xing Liu, Lipeng Qiu, Yifan Luo and Lixiang Ren and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Dawei Chen

223 papers receiving 7.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawei Chen China 49 3.1k 2.7k 2.2k 1.4k 772 230 7.6k
Xueqing Wang China 52 3.6k 1.2× 3.0k 1.1× 2.4k 1.1× 1.3k 1.0× 971 1.3× 227 8.4k
Hong Yuan China 53 3.0k 1.0× 3.0k 1.1× 2.2k 1.0× 1.8k 1.3× 687 0.9× 228 8.5k
Jianping Zhou China 45 2.7k 0.9× 3.1k 1.1× 2.7k 1.2× 1.2k 0.9× 838 1.1× 176 6.9k
Jaleh Barar Iran 53 3.0k 1.0× 2.4k 0.9× 2.5k 1.1× 1.0k 0.8× 1.0k 1.3× 208 7.9k
Ji Hoon Jeong South Korea 55 4.7k 1.5× 2.2k 0.8× 2.2k 1.0× 870 0.6× 1.2k 1.5× 183 9.0k
Xing Tang China 51 2.8k 0.9× 2.5k 1.0× 1.8k 0.8× 2.7k 2.0× 727 0.9× 349 8.9k
Qineng Ping China 49 3.1k 1.0× 3.5k 1.3× 2.0k 0.9× 2.8k 2.0× 671 0.9× 213 8.7k
Fuqiang Hu China 55 3.6k 1.2× 3.8k 1.4× 2.5k 1.1× 3.1k 2.3× 781 1.0× 203 9.2k
Yu Seok Youn South Korea 50 3.1k 1.0× 3.7k 1.4× 3.0k 1.4× 2.0k 1.5× 1.2k 1.6× 239 9.1k
Cui Tang China 41 2.5k 0.8× 2.6k 1.0× 1.7k 0.7× 1.6k 1.2× 933 1.2× 89 6.5k

Countries citing papers authored by Dawei Chen

Since Specialization
Citations

This map shows the geographic impact of Dawei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Chen more than expected).

Fields of papers citing papers by Dawei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Chen. The network helps show where Dawei Chen may publish in the future.

Co-authorship network of co-authors of Dawei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Dawei Chen. A scholar is included among the top collaborators of Dawei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawei Chen. Dawei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Linzhi, Ji Qian, Xiuli Guo, et al.. (2025). Radiotherapy in combination with PD-1 and TIGIT blockade mediate antitumor abscopal effects and immune memory via CD8+ T cells. Cancer Letters. 631. 217935–217935. 1 indexed citations
2.
Chang, Shuang, Guannan Guan, Ming Zhao, et al.. (2025). In Situ Remodeling of Tumor Microenvironment via Specific Cancer-Associated Fibroblasts Subtype Engineering to Boost Antitumor Immunity. ACS Nano. 19(43). 37815–37836.
3.
Gao, Yan, Zilin Song, Shuang Yu, et al.. (2024). Enhanced ferroptosis by a nanoparticle mimicking hemoglobin coordinate pattern with self-supplying hydrogen peroxide. Chinese Chemical Letters. 36(5). 110097–110097. 1 indexed citations
4.
Wang, Qi, et al.. (2024). Membrane Fusion Liposomes Deliver Antifibrotic and Chemotherapeutic Drugs Sequentially to Enhance Tumor Treatment Efficacy by Reshaping Tumor Microenvironment. Advanced Healthcare Materials. 13(20). e2400219–e2400219. 8 indexed citations
5.
Zhao, Ming, et al.. (2023). Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation. Journal of Controlled Release. 355. 211–227. 35 indexed citations
6.
7.
Zhao, Chaoyue, et al.. (2022). Multi-functional platelet membrane-camouflaged nanoparticles reduce neuronal apoptosis and regulate microglial phenotype during ischemic injury. Applied Materials Today. 27. 101412–101412. 21 indexed citations
8.
Huang, Ziyuan, Yuying Chen, Jiulong Zhang, et al.. (2021). Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy. ACS Applied Materials & Interfaces. 13(33). 39934–39948. 41 indexed citations
9.
10.
Jia, Nan, Jingjing Ma, Haiyang Hu, et al.. (2020). HA-Modified R8-Based Bola-Amphiphile Nanocomplexes for Effective Improvement of siRNA Delivery Efficiency. ACS Biomaterials Science & Engineering. 6(4). 2084–2093. 15 indexed citations
11.
Jia, Nan, Xirui Zhang, Wenpan Li, Dawei Chen, & Haiyang Hu. (2020). Phospholipid-Coated Guanosine Diphosphate Auxiliary CaP Active Nanoparticles Can Systematically Improve the Efficiency of Gene Therapy for Cancer Disease. ACS Biomaterials Science & Engineering. 6(4). 2107–2116. 4 indexed citations
12.
Fu, Jia, et al.. (2020). The Blood–Brain Barrier Cell-Targeted Gene Delivery System to Enhance Nerve Growth Factor Protein Secretion in the Brain. ACS Biomaterials Science & Engineering. 6(11). 6207–6216. 9 indexed citations
13.
Zhang, Xiaoxu, Xinlong Zang, Mingxi Qiao, et al.. (2020). Targeted Delivery of Dasatinib to Deplete Tumor-Associated Macrophages by Mannosylated Mixed Micelles for Tumor Immunotherapy. ACS Biomaterials Science & Engineering. 6(10). 5675–5684. 15 indexed citations
14.
Zang, Xinlong, Xiaoxu Zhang, Haiyang Hu, et al.. (2019). Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy. Molecular Pharmaceutics. 16(5). 2249–2258. 76 indexed citations
15.
Chen, Kang, Xiu Xin, Lipeng Qiu, et al.. (2019). Co-delivery of p53 and MDM2 inhibitor RG7388 using a hydroxyl terminal PAMAM dendrimer derivative for synergistic cancer therapy. Acta Biomaterialia. 100. 118–131. 18 indexed citations
16.
Li, Jia, Qi Wang, Haiyang Hu, et al.. (2019). pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells. ACS Applied Materials & Interfaces. 11(18). 16296–16310. 89 indexed citations
17.
Li, Wenpan, Jia Fu, Dan Liu, et al.. (2019). Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency. Acta Biomaterialia. 96. 456–467. 26 indexed citations
18.
Zang, Xinlong, Xiaoxu Zhang, Xiuli Zhao, et al.. (2019). Targeted Delivery of miRNA 155 to Tumor Associated Macrophages for Tumor Immunotherapy. Molecular Pharmaceutics. 16(4). 1714–1722. 51 indexed citations
19.
Li, Chenxi, Yue Lü, Qing Chen, et al.. (2019). Tailored Polymers with Complement Activation Ability To Improve Antitumor Immunity. Molecular Pharmaceutics. 16(6). 2648–2660. 6 indexed citations
20.
Liu, Yang, Qing Chen, Ming Xu, et al.. (2015). Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xueqing Wang Breakdown of academic impact, for papers by Hong Yuan Breakdown of academic impact, for papers by Jianping Zhou Breakdown of academic impact, for papers by Jaleh Barar Breakdown of academic impact, for papers by Ji Hoon Jeong Breakdown of academic impact, for papers by Xing Tang Breakdown of academic impact, for papers by Qineng Ping Breakdown of academic impact, for papers by Fuqiang Hu Breakdown of academic impact, for papers by Yu Seok Youn Breakdown of academic impact, for papers by Cui Tang
Rankless by CCL
2026